This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion.

Jerrold F. Rosenbaum, MD; Charles P. O†Brien, MD, PhD; Michael W. Otto, PhD; Boston; Mark H. Pollack, MD; Peter P. Roy-Byrne, MD; and Samantha A. Stewart, MD

Published: November 1, 2004

Article Abstract

Click to enlarge page

By highlighting issues from presentations he delivered in the 1980s, Dr. Rosenbaum provided an overview of benzodiazepine use. He stated that benzodiazepines were and still are widely used and offer symptomatic relief for some of humankind’s most prevalent and distressing conditions. One thing that has changed, Dr. Rosenbaum commented, is pharmacologic alternatives.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Anxiety

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...